Ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

被引:1
|
作者
Castellote, J [1 ]
Porta, F [1 ]
机构
[1] Hosp Gen Manresa, Secc Aparato Digest, Barcelona, Spain
来源
MEDICINA CLINICA | 2000年 / 115卷 / 03期
关键词
D O I
10.1016/S0025-7753(00)71481-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:118 / 119
页数:2
相关论文
共 50 条
  • [31] Ranitidine bismuth citrate in the treatment of Helicobacter Pylori infection
    Delgado, PH
    Feria, MR
    Castro, RR
    Olivares, FJM
    Rodríguez, BG
    Bautista, FJP
    Gutiérrez, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2002, 94 (01) : 22 - 24
  • [32] Comparison of 1-week vs. 2-or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
    Kamberoglou, D
    Polymeros, D
    Sanidas, I
    Doulgeroglou, V
    Savva, S
    Patra, E
    Tzias, V
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) : 1493 - 1497
  • [33] Characteristics of Helicobacter pylori motility and survival in the presence of ranitidine bismuth citrate, bismuth citrate and ranitidine hydrochloride
    Worku, M
    Karim, QN
    GASTROENTEROLOGY, 1997, 112 (04) : A1120 - A1120
  • [34] Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori -: Reply
    Malfertheiner, P
    Mégraud, F
    O'Morain, C
    GUT, 1998, 42 (04) : 597 - 597
  • [35] Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication
    Yakovenko, A
    Grigoriev, P
    Yakovenko, E
    Abazova, F
    Poliakov, A
    Agafonova, N
    Pryanishnikova, A
    Chtcherbina, E
    Gulyaev, P
    Gorodinskaya, V
    Avanyan, N
    GUT, 1999, 45 : A117 - A118
  • [36] Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication
    Uygun, A.
    Kadayifci, A.
    Yesilova, Z.
    Ates, Y.
    Safali, M.
    Ilgan, S.
    Bagci, S.
    Dagalp, K.
    HELICOBACTER, 2007, 12 (04) : 429 - 430
  • [37] Retreatment after failure of Helicobacter pylori eradication:: Quadruple vs ranitidine bismuth citrate two-week therapy
    Di Mario, F
    Salandin, S
    Dal Bo', N
    Pilotto, A
    Franceschi, M
    Grassi, SA
    De Bastiani, R
    Leandro, G
    Germaná, B
    Battaglia, G
    GUT, 1999, 45 : A115 - A115
  • [38] The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics
    McLaren, A
    Donnelly, C
    McDowell, S
    Williamson, R
    HELICOBACTER, 1997, 2 (01) : 21 - 26
  • [39] One-week therapy with omeprazole (PPI) or ranitidine bismuth citrate (RBC) and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer:: A preliminary report.
    Spinzi, GC
    Bortoli, A
    Corbellini, A
    Colombo, E
    Lanzi, GL
    Minoli, G
    GASTROENTEROLOGY, 1998, 114 (04) : A294 - A294
  • [40] Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer
    Catalano, F
    Catanzaro, R
    Bentivegna, C
    Brogna, A
    Condorelli, G
    Cipolla, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (01) : 59 - 62